NuLens, founded in 2002 and based in Herzliya Pituah, Israel, is a medical device company focused on developing the next generation of accommodating intraocular lenses based on the patents of Dr. Joshua Ben-nun. Intraocular lenses, or IOLs, are implantable devices offering the potential for glasses-free vision for patients with cataracts or poor vision. The first technology the Company is developing is an accommodating IOL that mimics the natural movement of the human eye, offering a material improvement in focusing power over currently available accommodating IOLs.
During 2006 and 2007, Warburg Pincus and Elron Electronic Industries led a $6 million series B investment and an $8 million series C investment, respectively, to fund continuing development and ongoing clinical trials of NuLens' accommodating IOL technology.
Back
to Previous Page